Fusion Protein Engineering & Developability Summit 2023

The Fusion Protein Engineering & Developability Summit is a premier event dedicated to the advancement of novel fusion protein engineering and its practical application in drug development. This summit brings together leading experts from pharmaceutical companies, including Roche, Merck & Co, and Asher Bio, to share their insights and experiences in designing and engineering functional and manufacturable fusion proteins.

With the rapid growth of novel fusion protein pipelines, there is an increasing need for effective engineering techniques that can accelerate the development of viable drugs for clinical use. This summit provides a comprehensive end-to-end engineering guide, addressing key challenges such as balancing immunogenicity, target specificity, and functionality to unlock enhanced therapeutic efficacy.

Participants of this summit will have the opportunity to explore recent advances in fusion protein engineering that have revolutionized the field, opening up new possibilities for drug development. Whether attendees are seeking to improve the activation of T-cells or NK cells, overcome challenges related to cytokine half-life and therapeutic window, or optimize assays for understanding developability, this event offers valuable insights and practical solutions.

The Fusion Protein Engineering & Developability Summit features three hands-on workshops and two days of data-driven case studies presented by industry leaders. These case studies will showcase real-world examples and highlight successful strategies employed by drug developers. By attending this summit, participants will not only gain in-depth knowledge but also have the opportunity to network with peers, fostering collaborations and exchange of ideas.

Whether you are a scientist, researcher, engineer, or executive involved in fusion protein engineering and drug development, this inaugural summit is an ideal platform to stay updated with the cutting edge of fusion application. Join this event to arm yourself with valuable insights and accelerate the progress of your drug candidates towards the clinic.